Clinigen appoints Sam Herbert as Chief Operating Officer

pharmafile | January 5, 2021 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing  

Clinigen, the global pharmaceutical and services company, has appointed Sam Herbert as Chief Operating Officer with immediate effect.

Herbert, who will be based in the UK, is an experienced international healthcare pharmaceutical executive with a background in driving growth and change in global supply and distribution businesses. Before joining Clinigen, he spent seven years at World Courier, a leading provider of specialty logistics and distribution services to the pharmaceutical, biotech and healthcare community. He joined as Vice President, Strategy, rising to become Chief Operating Officer and, finally, President. Prior to World Courier, Herbert worked for Oliver Wyman, a leading international management consulting firm, and built their Health & Life Sciences practice in Europe.

Shaun Chilton, Group Chief Executive Officer at Clinigen, said: “We have been building out Clinigen’s global platform in order to fully realise our vision of being the Trusted Global Leader in Access to Medicines. Now, more than ever, Clinigen has an important role to play in getting essential medicines across the world to the patients that need them.

“In adding the Chief Operating Officer role and with it, someone of Sam’s calibre and experience into the management team, this gives us more bandwidth and will significantly help us focus on executing our growth strategy and the significant number of opportunities the platform is creating.”

Related Content

No items found

Latest content